Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Optimizing the Differentiation of Cardiomyocytes from Human Induced Pluripotent-Derived Stem Cells. Methods Mol Biol 2021;2319:51-60

Date

08/01/2021

Pubmed ID

34331242

DOI

10.1007/978-1-0716-1480-8_6

Scopus ID

2-s2.0-85112650897

Abstract

Cardiovascular disease is a worldwide health issue that affects millions of lives every year, and thus, researchers are in need of high-throughput model systems with which to investigate mechanisms of disease and to develop and test potential therapies. The use of human-derived induced pluripotent stem cells (iPSCs) differentiated into cardiomyocytes aims to address this need. While cardiac differentiation protocols have been established previously in iPSCs, optimization of cardiac differentiation remains crucial to obtaining high quality cardiomyocytes for future experimental analyses. Important factors to consider include cell density and rate of proliferation, temporal regulation of media changes throughout the differentiation process, and the concentration of the chemicals utilized. In this chapter, we present a detailed protocol to outline the process of differentiating cardiomyocytes from human iPSCs via modulation of Wnt signaling, characterization of cardiomyocytes by immunofluorescence, as well as guidelines for troubleshooting and optimizing these techniques.

Author List

Gartz M, Strande JL

Author

Melanie Gartz PhD Assistant Professor in the Cell Biology, Neurobiology and Anatomy department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Cell Culture Techniques
Culture Media
Fluorescent Antibody Technique
Humans
In Vitro Techniques
Induced Pluripotent Stem Cells
Muscle Development
Myocytes, Cardiac
Wnt Signaling Pathway